• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Recent discoveries of influenza A drug target sites to combat virus replication

tetano

Editor, Senior Moderator
Biochem Soc Trans. 2016 Jun 15;44(3):932-6. doi: 10.1042/BST20160002.
[h=1]Recent discoveries of influenza A drug target sites to combat virus replication.[/h] Patel H[SUP]1[/SUP], Kukol A[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Sequence variations in the binding sites of influenza A proteins are known to limit the effectiveness of current antiviral drugs. Clinically, this leads to increased rates of virus transmission and pathogenicity. Potential influenza A inhibitors are continually being discovered as a result of high-throughput cell based screening studies, whereas the application of computational tools to aid drug discovery has further increased the number of predicted inhibitors reported. This review brings together the aspects that relate to the identification of influenza A drug target sites and the findings from recent antiviral drug discovery strategies.
? 2016 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society.


[h=4]KEYWORDS:[/h] antiviral discovery; influenza A; inhibitors; resistance; viral proteins

PMID: 27284062 [PubMed - in process]
 
Back
Top Bottom